Literature DB >> 42427

The effect of enzyme induction on diazepam metabolism in man.

E E Ohnhaus, B K Park, J P Colombo, P Heizmann.   

Abstract

1 The elimination and metabolism of diazepam in man was investigated following the induction of the liver microsomal enzyme system by antipyrine. 2 Seven healthy volunteers were given 1200 mg antipyrine as an inducing agent for a period of 14 days. Before and after the induction period the elimination of diazepam and desmethyldiazepam was measured in the plasma by gaschromatography. As parameters of liver microsomal enzyme activity, antipyrine elimination and gamma-glutamyl-transpeptidase in the plasma, D-glucaric acid and 6-beta-hydroxycortisol urinary excretion were measured on both occasions. 3 Following the induction period most parameters of microsomal enzyme activity measured were significantly changed indicating an increase of the microsomal enzyme system. The elimination of diazepam was significantly altered having a half-life of 37 h before and 18 h afterwards combined with a significant increase in total body clearance after the induction period, although the volume of distribution remained unaltered. The formation of the main metabolite N-desmethyldiazepam was not changed, but its elimination was increased having a half-life of 139 or 58 h respectively. 4 The elimination of unchanged diazepam and desmethyldiazepam is significantly increased by the induction of the liver microsomal enzyme system using antipyrine as an inducing agent in healthy volunteers, which might be important under certain clinical conditions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42427      PMCID: PMC1429902          DOI: 10.1111/j.1365-2125.1979.tb01044.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Induction effect of diazepam on its own metabolism.

Authors:  R Sellman; J Kanto; E Raijola; A Pekkarinen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-11

2.  Stimulatory effects of chlordiazepoxide, diazepam and oxazepam on the drug-metabolizing enzymes in microsomes.

Authors:  J K Jablońska; K Knobloch; J Majka; J M Wiśniewska-Knypl
Journal:  Toxicology       Date:  1975-09       Impact factor: 4.221

3.  The determination of 17,21-dihydroxy-20-ketosteroids in urine and plasma.

Authors:  R H SILBER; C C PORTER
Journal:  J Biol Chem       Date:  1954-10       Impact factor: 5.157

4.  Metabolism of d-glucuronolactone in mammalian systems. Identification of d-glucaric acid as a normal constituent of urine.

Authors:  C A Marsh
Journal:  Biochem J       Date:  1963-01       Impact factor: 3.857

5.  Determination of 1,4-benzodiazepines and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography.

Authors:  J A de Silva; I Bekersky; C V Puglisi; M A Brooks; R E Weinfeld
Journal:  Anal Chem       Date:  1976-01       Impact factor: 6.986

6.  Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.

Authors:  E E Ohnhaus; B K Park
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

7.  Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.

Authors:  S A Kaplan; M L Jack; K Alexander; R E Weinfeld
Journal:  J Pharm Sci       Date:  1973-11       Impact factor: 3.534

8.  Effect of phenobarbital on the in vitro metabolism of diazepam in several animal species.

Authors:  F Marcucci; R Fanelli; E Mussini; S Garattini
Journal:  Biochem Pharmacol       Date:  1970-05       Impact factor: 5.858

9.  A kinetic photometric method for serum gamma-glutamyl transpeptidase.

Authors:  G Szasz
Journal:  Clin Chem       Date:  1969-02       Impact factor: 8.327

10.  Changes in plasma -glutamyl transpeptidase activity associated with alterations in drug metabolism in man.

Authors:  J B Whitfield; D W Moss; G Neale; M Orme; A Breckenridge
Journal:  Br Med J       Date:  1973-02-10
View more
  12 in total

1.  The influence of enzyme induction on polymorphic sparteine oxidation.

Authors:  M Eichelbaum; S Mineshita; E E Ohnhaus; C Zekorn
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

Review 2.  Assessment of the drug metabolism capacity of the liver.

Authors:  B K Park
Journal:  Br J Clin Pharmacol       Date:  1982-11       Impact factor: 4.335

3.  Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 4.  Clinical implications of enzyme induction and enzyme inhibition.

Authors:  B K Park; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1981 Jan-Feb       Impact factor: 6.447

5.  Effect of antipyrine coadministration on the kinetics of acetaminophen and lidocaine.

Authors:  G T Blyden; D J Greenblatt; B W LeDuc; J M Scavone
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Single dose pharmacokinetic study of clobazam in normal volunteers and epileptic patients.

Authors:  S Jawad; A Richens; J Oxley
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 7.  Pharmacokinetic interactions with antiepileptic drugs.

Authors:  E Perucca
Journal:  Clin Pharmacokinet       Date:  1982 Jan-Feb       Impact factor: 6.447

Review 8.  Fulminant hepatic failure associated with status epilepticus in children: three cases and a review of potential mechanisms.

Authors:  M K Decell; J B Gordon; K Silver; K Meagher-Villemure
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

Review 9.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

10.  Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms.

Authors:  T Andersson; J O Miners; M E Veronese; D J Birkett
Journal:  Br J Clin Pharmacol       Date:  1994-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.